<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16</volume><submitter>Shitaye G</submitter><pubmed_abstract>Long COVID, or post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC), refers to a range of persistent health effects associated with SARS-CoV-2 infection. Long COVID is a complex, multisystem disorder that can affect nearly every organ system and is strongly linked with the incidence of diabetes and other chronic conditions. Increasing evidence also connects persistent SARS-CoV-2 infection with the development of new-onset diabetes and other metabolic disorders. In this review, we assess the current evidence and discuss the incidence of new-onset diabetes, along with the pathobiological mechanisms by which SARS-CoV-2 may contribute to the progression of both new-onset type 1 and type 2 diabetes mellitus (T1DM and T2DM). We summarize the latest</pubmed_abstract><journal>Frontiers in endocrinology</journal><pagination>1737894</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12756089</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Molecular analysis of long COVID and new-onset diabetes mellitus: pathobiological relationships and current mechanistic views.</pubmed_title><pmcid>PMC12756089</pmcid><pubmed_authors>D'Abrosca G</pubmed_authors><pubmed_authors>Fattorusso R</pubmed_authors><pubmed_authors>Mekonnen Z</pubmed_authors><pubmed_authors>Isernia C</pubmed_authors><pubmed_authors>Getie M</pubmed_authors><pubmed_authors>Amuamuta A</pubmed_authors><pubmed_authors>Shitaye G</pubmed_authors><pubmed_authors>Malgieri G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Molecular analysis of long COVID and new-onset diabetes mellitus: pathobiological relationships and current mechanistic views.</name><description>Long COVID, or post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC), refers to a range of persistent health effects associated with SARS-CoV-2 infection. Long COVID is a complex, multisystem disorder that can affect nearly every organ system and is strongly linked with the incidence of diabetes and other chronic conditions. Increasing evidence also connects persistent SARS-CoV-2 infection with the development of new-onset diabetes and other metabolic disorders. In this review, we assess the current evidence and discuss the incidence of new-onset diabetes, along with the pathobiological mechanisms by which SARS-CoV-2 may contribute to the progression of both new-onset type 1 and type 2 diabetes mellitus (T1DM and T2DM). We summarize the latest</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-06-06T11:15:11.699Z</modification><creation>2026-05-29T03:12:28.887Z</creation></dates><accession>S-EPMC12756089</accession><cross_references><pubmed>41488148</pubmed><doi>10.3389/fendo.2025.1737894</doi></cross_references></HashMap>